ECOR vs. IRIX, RMTI, BSGM, AIMDW, BBLGW, DHAIW, COCHW, HSCSW, IINNW, and NXLIW
Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include IRIDEX (IRIX), Rockwell Medical (RMTI), BioSig Technologies (BSGM), Ainos (AIMDW), Bone Biologics (BBLGW), DIH Holding US (DHAIW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), Inspira Technologies Oxy B.H.N. (IINNW), and Nexalin Technology (NXLIW).
electroCore (NASDAQ:ECOR) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.
IRIDEX has higher revenue and earnings than electroCore. IRIDEX is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.
In the previous week, IRIDEX had 1 more articles in the media than electroCore. MarketBeat recorded 3 mentions for IRIDEX and 2 mentions for electroCore. IRIDEX's average media sentiment score of 0.85 beat electroCore's score of 0.63 indicating that IRIDEX is being referred to more favorably in the news media.
electroCore has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.
IRIDEX has a net margin of -21.92% compared to electroCore's net margin of -88.12%. IRIDEX's return on equity of -105.42% beat electroCore's return on equity.
26.7% of electroCore shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 13.1% of electroCore shares are held by company insiders. Comparatively, 6.2% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
IRIDEX has a consensus target price of $2.00, indicating a potential downside of 17.70%. Given IRIDEX's higher probable upside, analysts clearly believe IRIDEX is more favorable than electroCore.
IRIDEX received 108 more outperform votes than electroCore when rated by MarketBeat users. Likewise, 69.04% of users gave IRIDEX an outperform vote while only 62.12% of users gave electroCore an outperform vote.
Summary
IRIDEX beats electroCore on 11 of the 18 factors compared between the two stocks.
Get electroCore News Delivered to You Automatically
Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
electroCore Competitors List
Related Companies and Tools
